Amryt Pharma Plc - ADR Stock, NASDAQ:AMYT
45 Mespil Road, Fitzwilliam Hall, Dublin, Dublin 4
Number of Employees:
Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. It operates through the Pharmaceutical segment, which is focused on the development and commercialization of commercial and development products. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded by Joseph Amrit Wiley and Rory Peter Nealon on August 28, 2015 and is headquartered in Dublin, Ireland.